Skip to main content
Intended for healthcare professionals
Free access
Research article
First published online January 4, 2019

An assessment of the cytotoxic effects of graphene nanoparticles on the epithelial cells of the human lung

Abstract

Nanomaterials are widely used nowadays in a range of technological and biomedical fields. Graphene as a nanomaterial used in the health-care sector and in workplaces has raised some concerns about its toxicity. This study aimed to evaluate the cytotoxicity of graphene nanoparticles (GNPs) on the A549 epithelial cells of the human lung. The GNPs were synthesized from graphite by the modified Hummer method. The physicochemical characteristics of GNPs were identified by the transmission electron microscope, the scanning electron microscope, and the Brunauer–Emmett–Teller method. The hydrodynamic size of GNPs in the dispersion media was examined using the dynamic light scattering technique. The GNPs were dispersed, after which the A549 cells were cultured. Finally, the cell viability was assayed by the MTT assay. The statistical analysis of variance was used to describe the relationship between the concentration/time variables and the GNP-induced cell deaths. The probit regression model was also used to achieve toxicological indicators. The results showed that the toxicological effects of GNPs on the A549 epithelial cells of the human lung are dose- and time-dependent. The GNPs were more cytotoxic after a 72-h exposure period compared to a 24-h and 48-h exposure period. The inhibitory concentration of 50% and “no observed adverse effect concentration” were estimated to be 40,653.1 and 0.059 µg/mL, respectively. The results of this study can be helpful in developing the occupational exposure limit for GNPs and in improving occupational health programs in workplaces. However, more investigation is needed to specify the toxicological mechanisms of GNPs.

Introduction

Graphene is a nanomaterial that was developed in 2004 using a simple technique (Sasidharan et al., 2013). It is an allotrope (form) of carbon consisting of a single layer of carbon atoms arranged in a hexagonal lattice (Geim, 2009). Nowadays, graphene nanoparticles (GNPs) are used in the health-care sector as a gene transducer and biosensor for the diagnosis of diseases and tissue engineering (Singh, 2018). GNPs have also attracted much attention because of their great potential for food safety and packaging (Becaro et al., 2015), agriculture (Hill et al., 2015), and industrial applications. This means workers worldwide are potentially exposed to GNPs. Consequently, concerns have been raised about the toxicity of GNPs (Goede et al., 2018). Several studies on the cytotoxicity of GNPs have indicated that the reactive oxygen species (ROS) increases in cells. ROS can damage proteins, DNA, and lipids, and may lead to many diseases (Seabra et al., 2014). Apoptosis, the programmed cell death (Sanchez et al., 2011), and necrosis, a type of cell injury that results in the premature death of cells in living tissue by autolysis, are important processes that accelerate cell death by GNPs (Li et al., 2012). The genotoxicity evaluation of GNPs has confirmed its carcinogenic potential in animal models (Zhang et al., 2015). Wang et al. (2011) have reported that a dose of 0.4 mg graphene oxide (GO) could cause granuloma formation in the kidneys, lungs, liver, and spleen and could not be filtered by the kidneys.
Recent studies have shown that when respiratory exposure to nanoparticles occurs, macrophages and neutrophils in the pulmonary system can be reactivated. In that case, it could produce an inflammatory reaction (Kennedy et al., 2009).
Since in vitro systems can assess the primary mechanisms of toxicity, they are known to be useful methods for the evaluation of toxicity of nanomaterials. Some of the advantages of in vitro systems are efficiency, rapidity, cost-effectiveness, and the fact that they provide base studies for animal research (Huang et al., 2010). However, the results of in vitro methods vary because of the differences in size, surface structure, functionalization, charge, impurities, aggregations, and the corona effect, and the sample preparation of nanomaterials. Therefore, cytotoxicity studies on nanomaterials need to be extended (Jastrzebska et al., 2012).
There are still uncertainties about the toxicity of GNPs. Research on the toxicological effects of GNPs is still limited, and even occupational exposure limits (OELs) have not yet been defined for GNPs (Mihalache et al., 2017). A better understanding of the relationship between the cytotoxicity of nanomaterials and the OEL would significantly extend our knowledge for establishing safe workplaces. A recent review showed that most of the studies on the cytotoxicity of GNPs are limited to the evaluation of the total lethal concentration (TLC) and inhibitory concentration of 50% (IC50) (Jastrzebska et al., 2012). The current study evaluated the “no observed adverse effect concentration” (NOAEC) as the highest experimental point without any adverse effects. Therefore, this study aimed to evaluate the cytotoxicity of GNPs on A549 epithelial cells of the human lung and provide basic data for identifying toxicological aspects of graphene clearly. This may be helpful in future risk assessment of exposed working groups in industries.

Method and materials

Synthesis of GNPs

GNPs were purchased with a purity of 99.98% from the Research Institute of Petroleum Industry (RIPI, Iran) (Sereshta et al., 2013). GNPs are synthesized from graphite by the modified Hummer method through RIPI. In this method, some graphite powder is added to a mixture of concentrated H2SO4 and fuming HNO3. The mixture is sonicated for 10 min and stirred for 30 min at 120°C. Then, it is cooled, diluted with deionized water, and neutralized with Na2CO3. The solution is filtered and dialyzed in a dialysis bag for 2 days. After the solution is concentrated on a rotary evaporator and filtered through 0.22-mm filters, a black solution is obtained. To obtain the graphene, the oxygen functional groups have to be eliminated. Hydrazine hydrate is used as the reducer. Finally, the solution is sonicated using the ultrasound method, heated in an oil bath, and refluxed under magnetic stirring at 70°C. The product is filtered and washed with additional ethanol to remove the residual hydrazine hydrate. Then, it is dried in an oven at 100°C.

Characterization of GNPs

The particle size and distribution of GNPs were measured by a transmission electron microscope (TEM; CM30-Philips, Japan) and a scanning electron microscope (SEM; S4160-Hitachi, Japan). The specific surface area and pore volume were calculated using the Brunauer–Emmett–Teller method (Romero et al., 2012). Because nanoparticle size and size distribution are important factors that affect in vitro toxicity, it was needed to characterize these parameters via dynamic light scattering (DLS). DLS is used as a simple method for analyzing suspension stability and measurement of particle size in solution to evaluate any nanoparticles such as metal and metal oxide and carbon-based nanomaterials (Murdock et al., 2007). The hydrodynamic sizes of GNPs in the dispersion media were examined using the DLS technique (Malvern Instruments Ltd, Zetasizer version 6.01) in a laboratory service company (Daypetronic, Iran).

Preparation of stock solution

The GNPs were dispersed using the generic nano-genotoxic dispersion protocol standard operation procedure (Jensen et al., 2011). In total, 15.36 g GNP was used to prepare a 2.56 mg/mL stock dispersion in 6 mL of ethanol and bovine serum albumin water (BSA-water). Then, 0.5% velum ethanol (96% or higher) and 99.5% velum sterile-filtered BSA-water (0.05% w/v) were used to disperse the GNPs.

Cell culture and exposure of GNPs

Human epithelial cell line, A549, was bought from the Cell Bank (Pasteur Institute of Iran, Tehran, Iran). The cells were cultured in Dulbecco Modified Eagle Medium (DMEM; BIO-IDEA, Iran) supplemented with 10% fetal bovine serum (BIO-IDEA, Iran), 100 U/mL penicillin, and 100 l µg/mL streptomycin (pen stripe). Then, the cells were incubated at 37°C in a humidified atmosphere (5% CO2 and 95% air).
After 24 h of incubation, the cells were seeded in a 96-well culture plate (1 × 103 cells/mL) and allowed to be attached to the plate for 24 h. The suspensions of the GNPs were dispersed by sonication (160 W, 20 kHz, 5 min) and diluted in various concentrations. Then, these were suspended in DMEM of 10 different concentrations (0.1, 1, 10, 50, 100, 200, 300, 500, 600, 1000 µg/mL) for 24, 48, and 72 h. The cells maintained in DMEM without GNPs were used as the control group. Two control groups, negative control and blank, were used in this study. In the negative control group, the wells contained only culture medium and cells. While, the wells containing culture medium and GNPs was specified as the blank control.

Cell morphology

The A549 epithelial cells were plated in the 96-well plates (103 cells per well) and incubated for 24 h. The GNPs were introduced to the cells in a predetermined concentration in the culture medium. The cells cultured in the medium without the addition of the GNPs were the control. The cell morphology was observed under an optical microscope (Olympus 1x71, equipped with Olympus DP72 Camera 12.8 megapixel, Japan) after 24 h.

Cell viability

The effect of GNPs on cell viability was determined by the MTT (3-[4, 5-dimethylthiazolyl-2]-2, 5-diphenyltetrazolium bromide) assay. The MTT assay is a colorimetric assay based on the ability of viable cells to reduce a soluble yellow tetrazolium salt to a purple Formosan crystal by the mitochondrial succinate dehydrogenase activity of viable cells.
According to this assay, the A549 epithelial cells were washed twice with phosphate-buffered saline (PBS). Ten microliters of MTT (5 mg/mL) supplemented with 150 µL complete culture medium were added to the plates and incubated for approximately 4 h. The surface medium was vacated and 150 µL dimethyl sulfoxide was added to dissolve the insoluble purple Formosan product into a colored solution. The cell plates were put into a shaker for 20 min. Finally, the optical density was read using a microplate reader (ELX800, BioTek model, Winooski, USA) at 570 nm.
In MTT method, some nanomaterials such as carbon nanotubes may interact with or adsorb the dye/dye products leading to invalid results. Therefore, the cells were washed twice with PBS before reading the adsorption of GNPs at 570 nm.

Statistical analysis and determination of toxicological indicators

The data were evaluated using SPSS-V16 software. To determine the relationship between concentration/time variables and GNP-induced cell death, the statistical analysis of variance (ANOVA) was used. The critical value for statistical significance was p < 0.05 with 95% confidence.
The collected data were also entered into the Minitab 18.1 software and the probit regression model was used to achieve the toxicological indicators. In addition, the descriptive data from three independent experiments were reported as the mean ± standard deviation.

Results

The obtained results were classified into three parts: characterization of GNPs, cell morphology, and toxicological indicators.

Characterization of GNPs

Figure 1 shows the SEM and a high-resolution TEM image of the GNPs. They have six sheets. The GNP sheets have micro and macro wrinkles and they fold at the edge, while the plates are larger. The main structural parameters of the GNPs are shown in Table 1. As it is shown, the pore size of the GNPs and the average pore diameter are approximately 2–50 nm and 13.28 nm, respectively.
Figure 1. (a) SEM and (b) high-resolution TEM image of GNPs. SEM: scanning electron microscopy; TEM: transmission electron microscopy: GNP: graphene nanoparticle.
Table 1. TEM, BET parametric structures of GNPs.
Parametric structures Dimension Parametric structures Dimension
Main pore size belongs to nanopores (nm) 2–50 Pore diameter (nm) 13.28
Number of layer 6 Crystal thickness (nm) 2
Layer distance (Å) 3.4 specific surface (m2/g) 195.97
Pore volume (cm3c/g) 0.0651    
TEM: transmission electron microscopy; BET: Brunauer–Emmett–Teller; GNP: graphene nanoparticle.
The average hydrodynamic diameter and the width of GNPs in the aqueous suspension were 323.3 nm and 80.05 nm, respectively. Figure 2 illustrates the size and number distribution of the GNPs in the DMEM culture medium.
Figure 2. Size distribution by number in DMEM culture medium. DMEM: Dulbecco Modified Eagle Medium.
Figure 3. Optical microscopy images of GNPs-treated A549 cells: (a) GNPs at 24 h, (b) the control at 24 h, (c) GNPs at 48 h, (d) the control at 48 h. GNP: graphene nanoparticle.
Figure 4. Dose–response graph for GNPs-treated A549 cells at different times. GNP: graphene nanoparticle.
Figure 5. Dose–response relationship for GNPs and A459 cell death, based on time, prepared by probit regression model. GNP: graphene nanoparticle.
Figure 6. Dose–response relationship for GNPs and A459 cell death, based on total versus concentration, by probit regression model. GNP: graphene nanoparticle.

Morphological changes of A549 cells induced by GNPs

The cell morphology, as the main indicator, expresses the status of the cells. The morphological changes were not observed in the GNP-treated and control cells following the GNP exposure. Neither the GNP-treated nor the control cells showed any differences in their adhesion to the culture medium dish. The majority of the cells had a spindle shape and adhered to the substrate normally (Figure 3).

Cell viability

The cell viability was assayed by MTT to demonstrate the cytotoxicity of GNPs in the A549 cells. The adsorption of GNP itself (0.012) was measured using similar methods and conditions and considered in calculations. Cell death was observed at higher concentrations of GNPs. For example, for 200 µg/mL GNP, the cell viability was 48% after 24 h of exposure. Almost similar results were obtained from 24- and 48-h exposures at the lowest concentration (less than 300 µg/mL), but the results were different for 72-h exposure. For example, for 100 µg/mL of GNP, the cell viability was 54.71% at 24 h and 54.48% at 48 h, but it was 47.56% after 72 h of exposure (Figure 4). Mean of cell death was 45.28 ± 20.14, 56.2 ± 27.14, and 60.9 ± 23.61 in 24, 48 and 72 h, respectively. According to the ANOVA test results, a significant relationship was observed between cell death with time of exposure to GNPs (p = 0.03) and exposed concentration (p = 0.00).
Nutrient depletion by nanomaterials is known to be a reason for nanotoxicity. Hence, the toxicity of GNPs on A549 cell culture was evaluated.
The DMEM medium was pretreated with separate GNP samples for 24 h, and then the supernatant liquid was collected for A549 cell culture. Had the cells died in the GNP-pretreated culture medium, it would be concluded that the adsorption of nutrients on to the nanomaterials influenced the toxicity of the culture medium. Nevertheless, the cells grew and so did the control cells. The cell viability did not decrease during the exposure.

Toxicological indicators

The toxicological indicators explain the relationship between the dose and the response. The TLC is the concentration of an inhibitor that reduces the response to zero. The IC50 is defined as the concentration of an inhibitor, which reduces the response by half. NOAEC is defined as the highest experimental point without any adverse effect. The NOAEC indicator is defined as the concentration of an inhibitor by which the response is reduced to 10% for new materials and unknown toxic materials such as nanomaterials (ISO, 2016). The toxicological indicators such as TLC, ICs, and NAOEC were attained by the probit regression model (Figure 5). The probit analysis is commonly used in toxicology to determine the relative toxicity of chemicals in living organisms/cells (Finney and Stevens, 1948). Toxicological data obtained were also displayed in Table 2.
Table 2. TLC, IC50, and NOAEC indicators for GNPs.
  Toxicology indicators (µg/mL)
Time exposure (h) NAOEC IC50 TLC
24 0.19 134.771 100,081
48 0.057 41.19 30,585
72 0.029 21.51 15,978
TLC: total lethal concentration; IC50: inhibitory concentration of 50%; GNP: graphene nanoparticle.
The probit regression was also used to illustrate the dose–response relationship based on the concentration regardless of the exposure time (Figure 6). In this respect, the TLC, IC50, and NOAEC were estimated to be 40,653.1, 41.15, and 0.059, respectively.

Discussion

The results of this study show that the GNPs reduced cell viability at high concentrations/doses. In other words, GNPs can be characterized as a toxin for the A549 epithelial cells of the human lung. There was a relatively good correlation between cytotoxicity and the exposure time. In addition, toxicological indicators illustrated the relationship between dose/time and response for GNPs. Several studies have confirmed the adverse effects of GNPs on organs and cells, too (Shang et al., 2014; Su et al., 2015). A study indicated that GNPs with 100–110 nm diameters had an increasing cytotoxic potential for pheochromocytoma and PC12 cells in rats. In addition, lactate dehydrogenase (LDH), ROS, and apoptosis were also released at 10–100 µg/mL for 48 h (Zhang et al., 2010).
Another study reported that GNPs with a size of 500–1000 nm increased the ROS levels and triggered apoptosis in murine RAW 264.7 macrophages in 5–100 mg/mL concentrations after a 48-h exposure (Li et al., 2012). Ma et al. found that the cytotoxicity of GO depends on the size of nanoparticles. Small nanosheets of graphene enter the cells mainly by endocytosis, whereas large graphene sheets are adsorbed onto the plasma membrane. Then, they enter the cells by phagocytosis, which may lead to the enhanced production of inflammatory cytokines and recruitment of immune cells (Ma et al., 2015). Therefore, the cytotoxicity of GNPs depends on the size of the nanoparticles. In the current study, GNPs at concentrations lower than 0.19 µg/mL exhibited remarkable cytotoxicity in the lung cells during the 24-h exposure period, while the diameters of GNPs were 2–50 nm. The results of the current study are in agreement with previously mentioned studies.
The mode of dispersion of the nanomaterials in the exposure tests is decisive for the outcome of in vitro studies. The agglomeration of GNPs, due to their differential dispersion ability, critically affects their ability to interact with the cells and, in turn, affects their internalization within the cells (Stone et al., 2009). In this study, DMEM containing 5% serum was chosen for dispersion, whereas the agglomeration of GNPs was moderate, and the size of the GNPs was 323.3 nm. In another study, the graphene agglomeration occurred following the dispersion in double-distilled water cells and on the cellular membrane, while the mean size of the nanoparticles was 349 ± 24 nm (Majeeda et al., 2016). It can be concluded that the agglomeration of GNPs might be related to their size.
The functionalized surface of GNPs may also affect cytotoxicity. Majeeda et al. found that solubility and toxicity could be influenced by changes in the surface properties. With respect to graphene surface chemistry, the pristine graphene exhibited the highest toxicological behavior (Majeeda et al., 2016). GNP-COOH and GNP-NH2 caused DNA damage, genotoxicity, and hypomethylation in human bronchial epithelial cells (BEAS-2B cells) at 10 and 50 mg/L after 24 h of exposure. Chatterjee et al. reported GNP toxicity higher than GNP-COOH and GNP-NH2 in a severe form of DNA damage. So, the concentration of 50 mg/mL was reported as the lowest effective concentration (Chatterjee et al., 2016). In this study, GNPs were pure and without a functionalized surface, but the TLC (or 99% death) of GNPs was obtained at 40.65 mg/mL. The obtained TLC results confirm that pristine GNPs are more toxic than functionalized surface GNPs.
According to the study by Chang et al., when GNPs were oxidized to GOs, cell viability decreased at a high concentration. They found that the GO did not enter the A549 cell and thus had no obvious cytotoxicity. Although the GO created ROS, IC20 was reported for 200 µg/mL in 24 h (Chang et al., 2011). In another study, cytotoxicity was observed at the highest GO concentration of 100 µg/mL (Schinwald et al., 2013; Zhang et al., 2012). When even graphene is changed to reduced graphene oxide (rGO), toxicity occurred in the highest concentration (100 µg/mL) (Akhavan et al., 2012; Jaworski et al., 2015). Chong synthesized the graphene quantum dots (GQD) from graphite and GO and evaluated the cytotoxicity. This compound of GO, which could improve the aqueous stability of GO, resulted in approximately 85% A459 cell viability at a concentration of 640 µg/mL (Chong, 2014). In the present study, IC50 was achieved at around 134.77 µg/mL in 24 h. The results of the current study justified the high toxicity of pristine GNPs, which is consistent with the results of similar studies.
This study indicated that cytotoxicity depends on the exposure period. GNPs were more cytotoxic after 72 h of exposure compared to a 24-h and 48-h exposure period. Chang et al. (2011) have reported similar results after 24, 48, and 72 h of exposure to GO and confirmed that the cytotoxicity of GNPs depends on the exposure period. Hence, cytotoxicity was dose- and time-dependent.
The obtained NOAEC results showed that GNPs are toxic for A459 cells in a 0.19 µg/mL concentration after an exposure for 24 h. In other words, IC10/24 for pristine GNPs was 0.19 µg/mL. Chang et al. (2011) reported IC20/24 of 200 µg/mL for GO. Since pristine GNPs are more toxic than other forms of GNPs (such as GO, rGO, and GQD), it can be proposed that the structure of nanomaterials can influence the NOAEC. Zhang et al. (2010) observed that a low dose of GNPs (0.01 µg/mL) could decrease PC12 cell viability, while it could not affect metabolic activity, LDH release, and ROS. It can be concluded that 0.01 µg/mL was the NOAEC indicator for GNPs. In other studies, Li et al. (2012) have reported that less than 20% of the RAW 264 cells remained in a concentration of 20 mg/mL. This indicates that the type of cell may influence the cytotoxicity.
Although the MTT measurement is a reliable toxicity marker, the assay has some inherent limitations. This measurement, which is a colorimetric assay, was used to determine the effect of cytotoxicity; it can evaluate cell viability without considering the toxicity mechanisms. It is recommended that toxicity mechanisms, such as oxidative stress, apoptosis, LDH, superoxide dismutase, and autophagy, which can influence cytotoxicity, be considered to evaluate the cytotoxicity of GNPs. A better understanding of toxicity mechanisms will justify the cytotoxicity and the toxicological indicators of GNPs.

Conclusion

The findings of the current study show that the viability of the A549 cells decrease with an increase in the concentration/dose of GNPs and the exposure period. In other words, the toxicological effects of GNPs on the A549 epithelial cells of the human lung are dose- and time-dependent. The NOAEC toxicological indicator for GNPs was 0.059 µg/mL. In addition to that, NOAEC may be related to the physicochemical properties of GNPs, the sample preparation, and the type of cell, which needs to be studied.
The results of this study can be helpful for development of the OEL for GNPs and risk evaluation of exposed population. However, more investigation is needed to clarify and specify the toxicological mechanisms of GNPs.

Acknowledgements

The authors thank the Research Institute of Neuroscience Research Center at the Shahid Beheshti University of Medical Sciences for laboratory services.

Declaration of Conflicting Interests

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding

The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was financially supported by the research deputy of the Tabriz University of Medical Sciences (grant number 57288).

ORCID iD

References

Akhavan O, Ghaderi E, Akhavan A (2012) Size-dependent genotoxicity of graphene nanoplatelets in human stem cells. Biomaterials 33(32): 8017–8025.
Becaro AA, Puti FC, Correa DS, et al. (2015) Polyethylene films containing silver nanoparticles for applications in food packaging: characterization of physico-chemical and anti-microbial properties. Journal of Nanoscience and Nanotechnology 15(3): 2148–2156.
Chang Y, Yang S, Liu J, et al. (2011) In vitro toxicity evaluation of graphene oxide on A549 cells. Toxicology Letters 200(3): 201–210.
Chatterjee N, Yang J, Choi J (2016) Differential genotoxic and epigenotoxic effects of graphene family nanomaterials (GFNs) in human bronchial epithelial cells. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 798–799: 1–10.
Chong Y (2014) The in vitro and in vivo toxicity of graphene quantum dots. Biomaterials 35: 5041–5048.
Finney D, Stevens WL (1948) A table for the calculation of working probits and weights in probit analysis. Biometrika 35(1–2): 191–201.
Geim AK (2009) Graphene: status and prospects. Science 324(5934): 1530.
Goede H, Vries YCD, Kuijpers E, et al. (2018) A review of workplace risk management measures for nanomaterials to mitigate inhalation and dermal exposure. Annals of Work Exposures and Health 62(8): 907–922.
Hill MR, Mackrell EJ, Forsthoefel CP (2015) Biodegradable and pH-responsive nanoparticles designed for site-specific delivery in agriculture. Biomacromolecules 16(4): 1276–1282.
Huang YW, Wu CH, Aronstam RS (2010) Toxicity of transition metal oxide nanoparticles: recent insights from in vitro studies. Materials 3(10): 4842–4859.
ISO (2016) Nanotechnologies—Occupational risk management applied to engineered nanomaterials. Geneva: International Organization Standardization.
Jastrzebska AM, Kurtycz P, Olszyna AR (2012) Recent advances in graphene family materials toxicity investigations. Journal of Nanoparticle Research 14: 1320.
Jaworski S, Sawosz E, Kutwin M, et al. (2015) In vitro and in vivo effects of graphene oxide and reduced graphene oxide on glioblastoma. International Journal of Nanomedicine 10: 1585–1596.
Jensen KA, Kembouche Y, Christiansen E, et al. (2011) Final protocol for producing suitable manufactured nanomaterial exposure media. København: The National Research Centre for the Working Environment.
Kennedy I, Wilson D, Baraka A (2009) Uptake and inflammatory effects of nanoparticles in a human vascular endothelial cell line. Research Report (Health Effects Institute) 2009 Jan(136): 3–32. Available at: https://pdfs.semanticscholar.org/2728/0abb24e0a6169a6d89171e68cdaa0605bfea.pdf.
Li Y, Liu Y, Fu Y, et al. (2012) The triggering of apoptosis in macrophages by pristine graphene through the MAPK and TGF-beta signaling pathways. Biomaterials 33(2): 402–411.
Ma J, Liu R, Wang X, et al. (2015) Crucial role of lateral size for graphene oxide in activating macrophages and stimulating proinflammatory responses in cells and animals. ACS (American Chemical Society) Nano 9(10): 10498–10515.
Majeeda W, Bourdoa Sh, Petiboneb DM, et al. (2016) The role of surface chemistry in the cytotoxicity profile of graphene. Journal of Applied Toxicology 37(4): 462–470.
Mihalache R, Verbeek J, Graczyk H, et al. (2017) Occupational exposure limits for manufactured nanomaterials, a systematic review. Nanotoxicology 11(1): 7–19.
Murdock R, Braydich-Stolle L, Schrand A, et al. (2007) Characterization of nanomaterial dispersion in solution prior to in vitro exposure using dynamic light scattering technique. Toxicological Sciences 101(2): 239–253.
Romero J, Rodriguez-San-Miguel D, Ribera A, et al. (2012) Metal-functionalized covalent organic frameworks as precursors of supercapacitive porous N-doped graphene. Journal of Materials Chemistry A 5: 4343–4351.
Sanchez VC, Jachak A, Hurt RH, et al. (2011) Biological interactions of graphene-family nanomaterials: an interdisciplinary review. Chemical Research in Toxicology 25(1): 15–34.
Sasidharan A, Panchakarl LS, Chandran P, et al. (2013) Differential nano-bio interactions and toxicity effects of pristine versus functionalized graphene. Nanoscale 3(6): 2461–2464.
Schinwald A, Murphy F, Askounis A, et al. (2013) Minimal oxidation and inflammogenicity of pristine graphene with residence in the lung. Nanotoxicology 8(8): 824–832.
Seabra AB, Paula AJ, Lima RD (2014) Nanotoxicity of graphene and graphene oxide. Chemical Research Toxicology 27(2): 159–168.
Sereshta RJ, Jahanshahia M, Rashidib A, et al. (2013) Synthesize and characterization of graphene nanosheets with high surface area and nano-porous structure. Applied Surface Science 276(1): 672–681.
Shang W, Zhang X, Zhang M, et al. (2014) The uptake mechanism and biocompatibility of graphene quantum dots with human neural stem cells. Nanoscale 6(11): 5799–5806.
Singh Z (2018) Applications and toxicity of graphene family nanomaterials and their composites. Nanotechnology, Science and Applications 9: 15–28.
Stone V, Johnston H, Schins RPF (2009) Development of in vitro systems for nanotoxicology: methodological considerations. Critical Reviews in Toxicology 36(7): 613–626.
Su WC, Ku BK, Kulkarni P, et al. (2015) Deposition of graphene nanomaterial aerosols in human upper airways. Journal of Occupational and Environmental Hygiene 13(1): 1–34.
Wang K, Ruan J, Song H, et al. (2011) Biocompatibility of graphene oxide. Nanoscale Research Letters 6: 1–8.
Zhang W, Hu W, Li G, et al. (2012) A comparative study of cellular uptake and cytotoxicity of multi-walled carbon nanotubes, graphene oxide, and nanodiamond. Toxicological Research 1(1): 62–68.
Zhang W, Yan L, Li M (2015) Deciphering the underlying mechanisms of oxidation-state dependent cytotoxicity of graphene oxide on mammalian cells. Toxicology Letters 237(2): 61–71.
Zhang Y, Ali S, Dervishi E, et al. (2010) Cytotoxicity effects of graphene and single-wall carbon nanotubes in neural phaeochromocytoma-derived PC12 cells. ACS (American Chemical Society) Nano 4(6): 3181–3186.

Cite article

Cite article

Cite article

OR

Download to reference manager

If you have citation software installed, you can download article citation data to the citation manager of your choice

Share options

Share

Share this article

Share with email
EMAIL ARTICLE LINK
Share on social media

Share access to this article

Sharing links are not relevant where the article is open access and not available if you do not have a subscription.

For more information view the Sage Journals article sharing page.

Information, rights and permissions

Information

Published In

Article first published online: January 4, 2019
Issue published: January 2019

Keywords

  1. Nanomaterials
  2. graphene nanoparticles
  3. cytotoxicity
  4. exposures
  5. MTT
  6. TLC
  7. IC50
  8. NOAEC

Rights and permissions

© The Author(s) 2018.
Request permissions for this article.
PubMed: 30803420

Authors

Affiliations

Nafiseh Nasirzadeh
Department of Occupational Health Engineering, Faculty of Health, Tabriz University of Medical Sciences, Tabriz, Iran
Mansur Rezazadeh Azari
Department of Occupational Health Engineering, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Yahya Rasoulzadeh
Department of Occupational Health Engineering, Faculty of Health, Tabriz University of Medical Sciences, Tabriz, Iran
Yousef Mohammadian
Department of Occupational Health Engineering, Faculty of Health, Tabriz University of Medical Sciences, Tabriz, Iran
Department of Occupational Health Engineering, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Notes

Yahya Rasoulzadeh, Faculty of Health, Tabriz University of Medical Sciences, Tabriz, Iran. Email: [email protected]

Metrics and citations

Metrics

Journals metrics

This article was published in Toxicology and Industrial Health.

VIEW ALL JOURNAL METRICS

Article usage*

Total views and downloads: 4113

*Article usage tracking started in December 2016


Articles citing this one

Receive email alerts when this article is cited

Web of Science: 27 view articles Opens in new tab

Crossref: 31

  1. Safety Considerations for Lyophilized Human Amniotic Membrane Impregna...
    Go to citation Crossref Google Scholar
  2. A review on toxicity mechanism and risk factors of nanoparticles in re...
    Go to citation Crossref Google Scholar
  3. Respiratory Toxicology of Graphene-Based Nanomaterials: A Review
    Go to citation Crossref Google Scholar
  4. Human epithelial lung cell toxicity assessment of collected graphite p...
    Go to citation Crossref Google Scholar
  5. Carbon Nanotubes and Graphene Materials as Xenobiotics in Living Syste...
    Go to citation Crossref Google Scholar
  6. Electrical Conductivity and Antibacterial Activity of Woven Fabrics th...
    Go to citation Crossref Google Scholar
  7. Progress in the application of graphene and its derivatives to osteoge...
    Go to citation Crossref Google Scholar
  8. A novel strategy for fabrication of antibacterial Kirschner wire via L...
    Go to citation Crossref Google Scholar
  9. Effect of graphene-based nanomaterials on corneal wound healing in vit...
    Go to citation Crossref Google Scholar
  10. Graphene-Related Nanomaterials for Biomedical Applications
    Go to citation Crossref Google Scholar
  11. Academic nanotechnology laboratories: investigating good practices and...
    Go to citation Crossref Google Scholar
  12. Nanosafety Analysis of Graphene-Based Polyester Resin Composites on a ...
    Go to citation Crossref Google Scholar
  13. Flake Graphene-Based Nanomaterial Approach for Triggering a Ferroptosi...
    Go to citation Crossref Google Scholar
  14. 3D Printed Graphene-PLA Scaffolds Promote Cell Alignment and Different...
    Go to citation Crossref Google Scholar
  15. Preliminary In Vitro Cytotoxicity, Mutagenicity and Antitumoral Activi...
    Go to citation Crossref Google Scholar
  16. Antibacterial Electroconductive Composite Coating of Cotton Fabric
    Go to citation Crossref Google Scholar
  17. Iranian National Standards regarding safety, health and environmental ...
    Go to citation Crossref Google Scholar
  18. Review on benefits, toxicity, challenges, and future of graphene-based...
    Go to citation Crossref Google Scholar
  19. Structure–Activity Relationship of Graphene-Based Materials: Impact of...
    Go to citation Crossref Google Scholar
  20. Toxicity risks of occupational exposure in 3D printing and bioprinting...
    Go to citation Crossref Google ScholarPub Med
  21. 8-Hydroxy-2′-deoxyguanosine (8-OHdG) as a biomarker of oxidative DNA d...
    Go to citation Crossref Google Scholar
  22. Factors affecting the biological response of Graphene
    Go to citation Crossref Google Scholar
  23. Antibacterial and antibiofilm properties of graphene and its derivativ...
    Go to citation Crossref Google Scholar
  24. Skin Sensitization Evaluation of Carbon-Based Graphene Nanoplatelets
    Go to citation Crossref Google Scholar
  25. Graphene-Based Scaffolds for Regenerative Medicine
    Go to citation Crossref Google Scholar
  26. Toxic impacts and industrial potential of graphene
    Go to citation Crossref Google Scholar
  27. Toxicology data of graphene-family nanomaterials: an update
    Go to citation Crossref Google Scholar
  28. Graphene oxide-induced neurotoxicity on neurotransmitters, AFD neurons...
    Go to citation Crossref Google Scholar
  29. Routes of Exposures and Toxicity of Nanoparticles
    Go to citation Crossref Google Scholar
  30. Graphenic Materials for Biomedical Applications
    Go to citation Crossref Google Scholar
  31. Individual and combined toxicity of carboxylic acid functionalized mul...
    Go to citation Crossref Google Scholar

Figures and tables

Figures & Media

Tables

View Options

View options

PDF/ePub

View PDF/ePub

Get access

Access options

If you have access to journal content via a personal subscription, university, library, employer or society, select from the options below:


Alternatively, view purchase options below:

Purchase 24 hour online access to view and download content.

Access journal content via a DeepDyve subscription or find out more about this option.